Hu D, Xia W, Weiner H
Mol Neurodegener. 2022; 17(1):59.
PMID: 36056406
PMC: 9437386.
DOI: 10.1186/s13024-022-00563-7.
Barnaba V
Front Immunol. 2022; 12:811968.
PMID: 35069600
PMC: 8771143.
DOI: 10.3389/fimmu.2021.811968.
Iwaszko M, Swierkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K
Clin Exp Immunol. 2015; 182(3):270-7.
PMID: 26307125
PMC: 4636889.
DOI: 10.1111/cei.12696.
Ma L, Simpson E, Li J, Xuan M, Xu M, Baker L
Blood. 2015; 126(2):247-56.
PMID: 26036802
PMC: 4505012.
DOI: 10.1182/blood-2015-03-635417.
Jiang X, Nicolls M
J Clin Invest. 2014; 124(3):967-70.
PMID: 24569371
PMC: 3938269.
DOI: 10.1172/JCI74701.
In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping.
Reuther S, Schmetzer H, Schuster F, Krell P, Grabrucker C, Liepert A
Clin Exp Med. 2012; 13(1):29-48.
PMID: 22441559
DOI: 10.1007/s10238-012-0180-y.
Historical overview of immunological tolerance.
Schwartz R
Cold Spring Harb Perspect Biol. 2012; 4(4):a006908.
PMID: 22395097
PMC: 3312674.
DOI: 10.1101/cshperspect.a006908.
A clonal model for human CD8+ regulatory T cells: unrestricted contact-dependent killing of activated CD4+ T cells.
Hu D, Liu X, Zeng W, Weiner H, Ritz J
Eur J Immunol. 2011; 42(1):69-79.
PMID: 22002875
PMC: 3251657.
DOI: 10.1002/eji.201141618.
Regulatory T cells for tolerance therapy: revisiting the concept.
LeGuern C
Crit Rev Immunol. 2011; 31(3):189-207.
PMID: 21740350
PMC: 3241987.
DOI: 10.1615/critrevimmunol.v31.i3.20.
CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.
Strioga M, Pasukoniene V, Characiejus D
Immunology. 2011; 134(1):17-32.
PMID: 21711350
PMC: 3173691.
DOI: 10.1111/j.1365-2567.2011.03470.x.
Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.
Bhowmick S, Clark R, Brocke S, Cone R
Int Immunol. 2011; 23(2):119-28.
PMID: 21273399
PMC: 3030727.
DOI: 10.1093/intimm/dxq461.
Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis.
Baughman E, Mendoza J, Ortega S, Ayers C, Greenberg B, Frohman E
J Autoimmun. 2011; 36(2):115-24.
PMID: 21257291
PMC: 3046327.
DOI: 10.1016/j.jaut.2010.12.003.
Immunology of gut mucosal vaccines.
Pasetti M, Simon J, Sztein M, Levine M
Immunol Rev. 2011; 239(1):125-48.
PMID: 21198669
PMC: 3298192.
DOI: 10.1111/j.1600-065X.2010.00970.x.
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Mars L, Saikali P, Liblau R, Arbour N
Biochim Biophys Acta. 2010; 1812(2):151-61.
PMID: 20637863
PMC: 5052066.
DOI: 10.1016/j.bbadis.2010.07.006.
Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.
York N, Mendoza J, Ortega S, Benagh A, Tyler A, Firan M
J Autoimmun. 2010; 35(1):33-44.
PMID: 20172692
PMC: 2878858.
DOI: 10.1016/j.jaut.2010.01.003.
T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis.
Volovitz I, Mor F, Machlenkin A, Machlenkin A, Goldberger O, Marmor Y
Immunology. 2009; 128(1):92-102.
PMID: 19689739
PMC: 2747142.
DOI: 10.1111/j.1365-2567.2009.03074.x.
Treating autoimmune disease by targeting CD8(+) T suppressor cells.
Konya C, Goronzy J, Weyand C
Expert Opin Biol Ther. 2009; 9(8):951-65.
PMID: 19522557
PMC: 2790919.
DOI: 10.1517/14712590903020759.
Inhibitory CD8+ T cells in autoimmune disease.
Suzuki M, Konya C, Goronzy J, Weyand C
Hum Immunol. 2008; 69(11):781-9.
PMID: 18812196
PMC: 2614126.
DOI: 10.1016/j.humimm.2008.08.283.
Pathogen induced regulatory cell populations preventing allergy through the Th1/Th2 paradigm point of view.
Roumier T, Capron M, Dombrowicz D, Faveeuw C
Immunol Res. 2008; 40(1):1-17.
PMID: 18193360
DOI: 10.1007/s12026-007-0058-3.
CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice.
Swain S, Meissner N, Harmsen A
Am J Pathol. 2006; 168(2):466-75.
PMID: 16436661
PMC: 1606479.
DOI: 10.2353/ajpath.2006.050724.
